2020 Corporate Partners
Thank you to our Corporate Partners for your continued support during COVID-19.
Platinum Partner
|
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries.
For more information, visit https://www.takeda.com Contacts: Stephen Gottlieb, PIDD Business Manager stephen.gottlieb@takeda.com 610-301-6793 Richard Bodinizzo, HAE Business Manager richard.bodinizzo@takeda.com 609-203-4628 |
Gold Partner
|
GlaxoSmithKline
5 Moore Drive Research Triangle Park, NC 27709 1-888-825-5249 GSK is a science-led global healthcare company with a mission to help people do more, feel better, live longer. We research, manufacture and make available a broad range of medicines, vaccines and consumer healthcare products. Visit our website for information about our products and resources. www.gsk.com Contacts: Julie Tebera julie.m.tebera@gsk.com Marcus Stanaland marcus.d.stanaland@gsk.com |
